James Healy

Affiliations

  • at Karuna Therapeutics Inc. (KRTX), 2024-03-18
  • Director at Arrivent Biopharma Inc. (AVBP), 2024-01-31
  • at Natera Inc. (NTRA), 2024-01-31
  • Director at Bolt Biotherapeutics Inc. (BOLT), 2023-06-14
  • Director at Y-Mabs Therapeutics Inc. (YMAB), 2023-06-09
  • Large Shareholder, Director at Cincor Pharma Inc. (CINC), 2023-02-28
  • Large Shareholder at Vera Therapeutics Inc. (VERA), 2023-02-08
  • Director at Coherus Biosciences Inc. (CHRS), 2022-02-11
  • Large Shareholder at Aerovate Therapeutics Inc. (AVTE), 2021-06-29
  • Large Shareholder at Checkmate Pharmaceuticals Inc. (CMPI), 2020-08-13
  • Large Shareholder at Inozyme Pharma Inc. (INZY), 2020-07-28
  • Large Shareholder at Akouos Inc. (AKUS), 2020-07-02
  • Large Shareholder at Iterum Therapeutics Plc (ITRM), 2020-06-04
  • Large Shareholder at Nextcure Inc. (NXTC), 2019-11-20
  • Large Shareholder at Galera Therapeutics Inc. (GRTX), 2019-11-12
  • Large Shareholder at Entasis Therapeutics Holdings Inc. (ETTX), 2018-10-03
  • Large Shareholder at Principia Biopharma Inc. (PRNB), 2018-09-20
  • Director at Edge Therapeutics Inc. (EDGE), 2017-06-21
  • Large Shareholder at Marinus Pharmaceuticals Inc (MRNS), 2016-10-24
  • Director at Amarin Corp Plc (AMRN), 2016-07-13
  • Large Shareholder at Aclaris Therapeutics Inc. (ACRS), 2015-10-13
  • Large Shareholder at Mirna Therapeutics Inc. (MIRN), 2015-10-06
  • Large Shareholder at Atyr Pharma Inc (LIFE), 2015-05-15
  • Large Shareholder, Director at Hyperion Therapeutics Inc (HPTX), 2015-05-09
  • Large Shareholder at Spark Therapeutics Inc. (ONCE), 2015-01-30
  • Large Shareholder at Histogenics Corp (HSGX), 2014-12-10
  • Director at Intermune Inc (ITMN), 2014-10-02
  • Large Shareholder at Alimera Sciences Inc (ALIM), 2014-09-15
  • Large Shareholder at Aerie Pharmaceuticals Inc (AERI), 2014-07-12
  • Large Shareholder at Versartis Inc. (VSAR), 2014-03-28
  • Large Shareholder at Ocera Therapeutics Inc. (OCRX), 2014-03-20
  • at Anthera Pharmaceuticals Inc (ANTH), 2013-05-20
  • Director at Kalobios Pharmaceuticals Inc (KBIO), 2013-05-03
  • Large Shareholder, Director at Durata Therapeutics Inc. (DRTX), 2012-07-25
  • Large Shareholder at Trius Therapeutics Inc (TSRX), 2012-01-17
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AVBP $18.00 444,444 Director 1,696,752 2024-01-30 Filing
CINC $30.00 6,000 Large Shareholder, Director 6,000 2022-08-11 Filing
CINC $30.00 500,000 Large Shareholder, Director 6,073,949 2022-08-11 Filing
KRTX $123.39 24,161 Director 2,072,441 2022-06-30 Filing
KRTX $122.27 48,062 Director 2,048,280 2022-06-30 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NTRA $58.75 644,000 Director 0 2023-12-13 Filing
CINC $14.32 6,000 Large Shareholder, Director 0 2022-11-28 Filing
NTRA $37.71 2,400 Director 0 2022-11-16 Filing
KRTX $199.90 6,027 Director 0 2023-01-13 Filing
CHRS $16.12 286,076 Director 0 2021-09-29 Filing